The Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Iclepertin (BI 425809): Results from Two Phase I Open-Label, Non-randomised, Single Dose, Parallel Design Studies.
- DOI
- 10.1007/s40268-026-00537-w
- Published
- 2026 Mar
- Container
- Drugs in R&D
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40268-026-00537-w,
title = {The Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Iclepertin (BI 425809): Results from Two Phase I Open-Label, Non-randomised, Single Dose, Parallel Design Studies.},
author = {Choi H and Madari S and Daalman E and English BA and Halabi A and Hohl K and Shatillo Y and Weidinger N and Desch M},
year = {2026},
journal = {Drugs in R\&D},
doi = {10.1007/s40268-026-00537-w},
url = {https://doi.org/10.1007/s40268-026-00537-w}
}RIS
TY - JOUR TI - The Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Iclepertin (BI 425809): Results from Two Phase I Open-Label, Non-randomised, Single Dose, Parallel Design Studies. AU - Choi H AU - Madari S AU - Daalman E AU - English BA AU - Halabi A AU - Hohl K AU - Shatillo Y AU - Weidinger N AU - Desch M PY - 2026 JO - Drugs in R&D DO - 10.1007/s40268-026-00537-w UR - https://doi.org/10.1007/s40268-026-00537-w ER -
APA
H, C., S, M., E, D., BA, E., A, H., K, H., Y, S., N, W., & M, D. (2026). The Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Iclepertin (BI 425809): Results from Two Phase I Open-Label, Non-randomised, Single Dose, Parallel Design Studies.. Drugs in R&D. https://doi.org/10.1007/s40268-026-00537-w
Source records
- pubmed · retrieved 2026-09-25T05:05:34.603Z
- europe-pmc · retrieved 2026-09-25T05:05:34.636Z
- doaj · retrieved 2026-09-25T05:05:34.605Z